From USFDA
Strides Shasun has received approval from USFDA for Omega-3-Acid Ethyl Esters Softgel capsules, a generic version of Lovaza.The US market for Lovaza is approximately USD 300 million per annum as per IMS.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
